Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Teligent, Inc. (TLGT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.1735-0.0279 (-13.85%)
At close: 03:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2014
Open0.2070
Bid0.1718 x 900
Ask0.1729 x 1000
Day's Range0.1650 - 0.2090
52 Week Range0.0200 - 1.6000
Volume72,246,596
Avg. Volume7,974,305
Market Cap16.104M
Beta (5Y Monthly)1.69
PE Ratio (TTM)N/A
EPS (TTM)-4.3090
Earnings DateDec 29, 2021 - Jan 03, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Benzinga

    22 Stocks Moving in Friday's Pre-Market Session

    Gainers LM Funding America, Inc. (NASDAQ: LMFA) rose 39.5% to $4.80 in pre-market trading after declining around 15% on Thursday. The company recently announced it purchased an additional 4,000 S19J Pro Antminer Machines for a price of $25.3 million to further expand the company's mining capabilities. ABVC BioPharma, Inc. (NASDAQ: ABVC) rose 24.4% to $3.06 in pre-market trading after gaining around 5% on Thursday. ABVC BioPharma recently restructured its joint venture with Lucida. Avadel Pharmac

  • American City Business Journals

    Generic drug maker Teligent files for bankruptcy protection, explores sale of the company

    South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy protection on Thursday as it pursues the sale of the company or its core assets. Teligent Inc. of Buena in Atlantic County also said it is arranging for $12 million debtor-in-possession financing from its senior secured lenders. The company also announced that CEO Tim Sawyer and Philip Yachmetz, Teligent's chief legal officer and executive vice president, resigned effective Oct. 8.

  • PR Newswire

    Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process

    Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company ("Teligent" or the "Company"), today announced that the Company has, together with certain of its affiliates, filed for voluntary protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware to pursue a sale process that is intended to maximize the value of the Company.

Advertisement
Advertisement